Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Pyridoxamine Supplementation on Vascular Function and Insulin Sensitivity; a Double-blind Randomized Placebo Controlled Trial in Abdominally Obese Subjects.

NCT02954588 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT02954588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02954588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Pyridoxamine Supplementation on Vascular Function and Insulin Sensitivity; a Double-blind Randomized Placebo Controlled Trial in Abdominally Obese Subjects.
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
October 14, 2016
Completion date
August 8, 2020
Enrollment
112 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal obesity metabolic syndrome